ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
NovoEight 250 IE, Injektionspräparat - Durchstechflasche(n)
63014001 PPNovo Nordisk Pharma AG
NovoEight 250 IE, Injektionspräparat18.02.2014
  18.02.2014
Coagulation Factor Viii (B02BD02) 
WHO-DDD 
06.01.10.Durchstechflasche(n)
06.01.10. 
B  
Yes 
IPCI
203.66Yes
    
10 %250.00
  
7680630140012Biotechnologika
5943611 
Composition
Praeparatio cryodesiccata: turoctocogum alfa 250 U.I., histidinum, saccharum, polysorbatum 80, natrii chloridum, methioninum, calcii chloridum dihydricum, pro vitro. Solvens: natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 4 ml.
Packungsbestandteile
Praeparatio cryodesiccata:
 
Injection preparation 
  
 
Active AgentDose
Turoctocogum Alfa250 UI
BAG: Active AgentDose
Turoctocogum Alfa250 UI
 
Inactive agents
Calcium Chloride
Histidine
Methionine
Sodium Chloride
Polysorbatum 80
Saccharum
 
Solvens
 
Injection preparation 
  
  
BAG: Active AgentDose
Turoctocogum Alfa250 UI
 
Inactive agents
Sodium Chloride
 
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home